Effects of adenosine on prostate adenocarcinoma PC-3 and bladder carcinoma J82 cell lines

Drug Development Research

Volumn 58, Issue 4, 2003, Pages 390-395

  Nucciarelli, Fabio ^a   Mearini, Ettore ^a   Minelli, Alba ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Adenosine; Apoptosis; Growth inhibition

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; DEOXYADENOSINE; DIPYRIDAMOLE;

APOPTOSIS; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; PROSTATE ADENOCARCINOMA;

EID: 0037712619     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10183     Document Type: Conference Paper

References (29)

1. Abbracchio MP. 1996. P1 and P2 receptors in cell growth and differentiation. Drug Dev Res 38:393-406.
2. Abbracchio MP, Brambilla R, Ceruti S, Kim HO, von Lubitz DK, Jacobson KA, Cattabeni F. 1995a. G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain. Mol Pharmacol 48:1038-1045.
3. Abbracchio MP, Ceruti S, Barbieri D, Franceschi C, Malorni W, Biondo L, Burnstock G, Cattabeni F. 1995b. A novel action for adenosine: apoptosis of astroglial cells in rat brain primary cultures. Biochem Biophys Res Commun 213:908-915.
4. Bajaj S, Insel J, Quagliata F, Hirschhorn R, Silber R. 1983. Adenosine and adenosine analogues are more toxic to chronic lymphocytic leukemia than to normal lymphocytes. Blood 62:75-80.
5. Bergmeyer HU. 1963. Methods of enzymatic analysis. Verlag chemie GMBH Weinheim/Bergstr. New York: Academic Press. p 502-504.
6. Brambilla, R, Cattabeni F, Ceruti S, Barbieri D, Franceschi C, Kim YC, Jacobson KA, Klotz KN, Lohse MJ, Abbracchio MP. 2000. Activation of the A3 adenosine receptor affects cell cycle progression and cell growth. Naunyn Schmied Arch Pharmacol 361:225-234.
7. Colquhoun A, Newsholme EA. 1997. Inhibition of human tumour cell proliferation by analogues of adenosine. Cell Funct 15:135-139.
8. Dawicki DD, Chatterjee D, Wyche J, Rounds S. 1997. Extracellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cells. Am J Physiol 273:L485-494.
9. Dubey RK, Gillespie DG, Mi Z, Suzuki F, Jackson EK. 1996a. Smooth muscle cell-derived adenosine inhibits cell growth. Hypertension 27:766-773.
10. Dubey RK, Gillespie DG, Osaka K, Suzuki F, Jackson EK. 1996b. Adenosine inhibits growth of rat aortic smooth muscle cells. Possible role of A2b receptor. Hypertension 27:786-793.
11. Fishman P, Bar-Yehuda S, Vagman L. 1998. Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. Cancer Res 15:3181-3187.
12. Fishman P, Bar-Yehuda S, Farbstein T, Barer F, Ohana G. 2000a. Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors. J Cell Physiol 183:393-398.
13. Fishman P, Bar-Yehuda S, Ohana G, Pathak S, Wasserman L, Barer F, Multani AS. 2000b. Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor. Eur J Cancer 36:1452-1458.
14. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W. 2000. Structure and function of adenosine receptors and their genes. Naunyn Schmied Arch Pharmacol 362:364-374.
15. Lelièvre V, Muller JM, Falcon J. 1998a. Adenosine modulates cell proliferation in human colonic adenocarcinoma. I. Possible involvement of adenosine A1 receptor subtypes in HT29 cells. Eur J Pharmacol 341:289-297.
16. Lelièvre V, Muller JM, Falcon J. 1998b. Adenosine modulates cell proliferation in human colonic carcinoma. II. Differential behavior of HT29, DLD-1, Caco-2 and SW403 cell lines. Eur J Pharmacol 341:299-308.
17. Lewis MD, Hepburn PJ, Scanlon MF. 1997. Epidermal growth factor protects GH3 cells from adenosine induced growth arrest. Mol Cell Endocrinol 127:137-142.
18. MacLaughlin M, Martinez-Salgado C, Eleno N, Olivera A, Lopez-Novoa JM. 1997. Adenosine activates mesangial cell proliferation. Cell Signal 9:59-63.
19. Minelli A, Allegrucci C, Liguori L, Ronquist G. 2002. Ectodiadenosine polyphosphates hydrolase activity on human prostasomes. Prostate 51:1-9.
20. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
21. Ohana G, Bar-Yehuda S, Barer F, Fishman P. 2001. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. J Cell Physiol 186:19-23.
22. Plagemann PG, Aran JM, Wohlhueter RM, Woffendin C. 1990. Mobility of nucleoside transporter of human erythrocytes differs greatly when loaded with different nucleosides. Biochim Biophys Acta 1022:103-109.
23. Sandberg G. 1983. Regulation of thymocyte proliferation by endogenous adenosine and adenosine deaminase. Int J Immunopharmacol 5:259-265.
24. Shimegi S. 1998. Mitogenic action of adenosine on osteoblast-like cells, MC3T3-E1. Calcif Tissue Int 62:418-425.
25. Stone TW, Collis MG, Williams M, Miller LP, Karasawa A, Hillaire-Buys D. Adenosine: some therapeutic applications and prospects. In: Cuello AC, Collier B, editors. Pharmacological sciences: perspectives for research and therapy in the late 1990s. Basel: Birkhäuser. p 304-309.
26. Tanaka Y, Yoshihara K, Tsuyuki M, Kamiya T. 1994. Apoptosis induced by adenosine in human leukemia HL-60 cells. Exp Cell Res 213:242-252.
27. Tey HB, Khoo HE, Tan CH. 1992. Adenosine modulates cell growth in human epidermoid carcinoma (A431) cells. Biochem Biophys Res Commun 187:1486-1492.
28. Van der Wenden EM, von Frijtag Drabbe Kunzel JK, Mathot RA, Danhof M, IJzerman AP, Soudijn W. 1995. Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor. J Med Chem 38:4000-4006.
29. Wakada TD, Palmer KC, McCauley R, Przywara DA, Wakade AR. 1995. Adenosine-induced apoptosis in chick embryonic sympathetic neurons: a new physiological role for adenosine. J Physiol 488:123-138.